ciprofloxacin has been researched along with lipid a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, NH; Bowman, JL; Endsley, S; Guan, Z; McClerren, AL; Raetz, CR; Rudolph, J | 1 |
Bauer, ME; Baye, FM; Fortney, KR; Janowicz, DM; Katz, BP; Post, DM; Reinders, LM; Rinker, SD; Spinola, SM; Trombley, MP; Zwickl, BW | 1 |
2 other study(ies) available for ciprofloxacin and lipid a
Article | Year |
---|---|
A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin.
Topics: Amidohydrolases; Anti-Bacterial Agents; Ciprofloxacin; Enzyme Inhibitors; Hydroxamic Acids; Lipid A; Magnetic Resonance Spectroscopy; Models, Molecular; Threonine; Zinc | 2005 |
Phosphoethanolamine Transferase LptA in Haemophilus ducreyi Modifies Lipid A and Contributes to Human Defensin Resistance In Vitro.
Topics: Administration, Oral; Adult; alpha-Defensins; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; beta-Defensins; Cathelicidins; Chancroid; Ciprofloxacin; Drug Resistance, Bacterial; Ethanolaminephosphotransferase; Ethanolamines; Female; Gene Deletion; Gene Expression; Genetic Complementation Test; Haemophilus ducreyi; Healthy Volunteers; Humans; Lipid A; Male; Mutation; Protein Binding; Static Electricity | 2015 |